News for AstraZeneca PLC (AZN.L)

Before taking office last July, UK Chancellor of the Exchequer Rachel Reeves met business leaders over a series of breakfasts that became known as the

The government is trying to balance business, unions, and a divided electorate. At the moment, it doesn’t appear to be satisfying any of them.

PR NewswireSAN DIEGO, July 4, 2025 SAN DIEGO, July 4, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers of Tempus AI, Inc. (N

AstraZeneca PLC (NASDAQ:AZN) is one of the 11 Best Strong Buy Stocks to Invest in Now. On June 13, AstraZeneca PLC (NASDAQ:AZN) announced that it had entered into a strategic research collaboration with CSPC Pharmaceuticals Group Limited, based in Shijiazhuang City. The research collaboration aims to discover and develop novel oral candidates with the hopes […]

July is observed as Sarcoma Awareness Month. Sarcoma is a rare type of cancer that affects muscles, fat, nerves, and other connective tissues. As we get ready to welcome July, it's also time to track the important FDA decisions lined up for the month.

AstraZeneca PLC (NASDAQ:AZN) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company announced that the FDA had granted accelerated approval to Datroway for the treatment of adult patients with non-small cell lung cancer (NSCLC). Datroway is the first and only TROP2-directed antibody-drug conjugate (ADC) approved […]

PR NewswireSAN DIEGO, June 27, 2025 SAN DIEGO, June 27, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of

VANCOUVER, BC / ACCESS Newswire / June 27, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to anno

One of the most read (and recommended) books on investing is Benjamin Graham’s The Intelligent Investor. Among many others, long-term investing is a foundational theme in the book.

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June 26, 2025 (GLOBE NEWSWIRE) -- The Portnoy

AstraZeneca (AZN) announced that its drug, Datroway, has received approval in the United States for treating adult patients with locally advanced or metastatic

PR NewswireSAN DIEGO, June 18, 2025 SAN DIEGO, June 18, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers of Tempus AI, Inc.

Current weight-loss methods and popular therapies like Wegovy and Zepbound result in both fat and muscle loss, which could be especially harmful for older patients.

The Trump administration is contemplating new regulations that could impose additional barriers on pharmaceutical companies like AstraZeneca (AZN) when advertis

Insights from the First Quarter of 2025 N-PORT Filing Vanguard Health Care Fund (Trades, Portfolio) recently submitted its N-PORT filing for the first quarter

MSFT, AZN, and BLK earn praise in fresh Zacks reports, with AI, pharma pipelines, and AUM growth fueling long-term outlooks.

Jefferies has started coverage on Mineralys Therapeutics (MLYS) with a Hold rating, setting a price target of $15. Mineralys is developing an innovative blood p

AstraZeneca (AZN) is poised to be affected by a significant restructuring of the U.S. vaccine advisory process. Recent announcements indicate a complete reconst

Amidst various pharmaceutical and vaccine companies, AstraZeneca (AZN) stands as a significant player. This company, alongside others in the industry, drives in